Prevention of Post Operative Urinary Retention After Thoracic Surgery Trial

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age40+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

The objectives of this study are to determine the feasibility of conducting a full-scale randomized control trial comparing the efficacy of tamsulosin compared to placebo in reducing post-operative urinary retention in people undergoing elective thoracic surgery.

Eligibility criteria

Qualifiers

Male Sex

Age greater than or equal to 40 years

History of Diabetes Mellitus

Prior pelvic irradiation

Disqualifiers

Active treatment of Benign Prostatic Hyperplasia (BPH)

Hypersensitivity or allergy to tamsulosin HCL

Active treatment with tamsulosin or other alpha-blocker or uses of tamsulosin/ other alpha-blocker within 3 weeks of enrollment date

Active urinary tract infection

Trial design

Treatments tested in this trial

  • Tamsulosin Hydrochloride
  • Placebo

Treatment groups

60 Participants
are divided into 2 treatment groups